Anixa Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIX and other ETFs, options, and stocks.

About ANIX

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. 

CEO
Amit D. Kumar
CEOAmit D. Kumar
Employees
4
Employees4
Headquarters
San Jose, California
HeadquartersSan Jose, California
Founded
1982
Founded1982
Employees
4
Employees4

ANIX Key Statistics

Market cap
102.38M
Market cap102.38M
Price-Earnings ratio
-9.52
Price-Earnings ratio-9.52
Dividend yield
—
Dividend yield—
Average volume
356.49K
Average volume356.49K
High today
$2.99
High today$2.99
Low today
$2.75
Low today$2.75
Open price
$2.83
Open price$2.83
Volume
434.48K
Volume434.48K
52 Week high
$5.46
52 Week high$5.46
52 Week low
$2.32
52 Week low$2.32

Stock Snapshot

With a market cap of 102.38M, Anixa Biosciences(ANIX) trades at $2.93. The stock has a price-to-earnings ratio of -9.52.

On 2026-10-03, Anixa Biosciences(ANIX) stock traded between a low of $2.75 and a high of $2.99. Shares are currently priced at $2.93, which is +6.6% above the low and -2.0% below the high.

Anixa Biosciences(ANIX) shares are trading with a volume of 434.48K, against a daily average of 356.49K.

During the past year, Anixa Biosciences(ANIX) stock moved between $2.32 at its lowest and $5.46 at its peak.

During the past year, Anixa Biosciences(ANIX) stock moved between $2.32 at its lowest and $5.46 at its peak.

ANIX News

Investing.com 3d
Anixa doses second patient in ovarian cancer CAR-T trial - Investing.com

...

Anixa doses second patient in ovarian cancer CAR-T trial - Investing.com
TipRanks 3d
Anixa Biosciences says second patient treated in CAR-T ovarian cancer trial

Anixa Biosciences (ANIX) announced that the second patient has been treated in the fifth cohort of its ongoing Phase 1, dose-escalating, clinical trial evaluati...

TipRanks 3d
Top Anixa Executive Makes Bold Insider Move in Latest Stock Buy

New insider activity at Anixa Biosciences ( (ANIX) ) has taken place on September 30, 2026. Anixa Biosciences has drawn investor attention after its President,...

More ANIX News

Simply Wall St 3d
Anixa Biosciences And 2 Other Penny Stocks Worth Watching

Over the past 7 days, the U.S. market has experienced a slight drop of 1.5%, although it remains up by 12% over the last year with earnings forecasted to grow b...

Anixa Biosciences And 2 Other Penny Stocks Worth Watching
TipRanks 5d
Top Brass Double Down on Anixa Biosciences With Fresh Insider Buys

New insider activity at Anixa Biosciences ( (ANIX) ) has taken place on September 28, 2026. Anixa Biosciences has seen notable insider buying activity, signali...

People also own

Based on the portfolios of people who own ANIX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.